title: Duration of dual antiplatelet therapy after coronary artery stenting: where is the sweet spot between ischaemia and bleeding?
authors.affiliation: Editorial Office, European Heart Journal, Zurich Heart House, Careum Campus, Moussonstreet 4, Zurich 8091, Switzerland.
authors.forename: Ronald K
authors.initials: RK
authors.lastname: Binder
authors.affiliation: Editorial Office, European Heart Journal, Zurich Heart House, Careum Campus, Moussonstreet 4, Zurich 8091, Switzerland thomas.luescher@usz.ch.
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Lüscher
mesh_terms: D054058:Acute Coronary Syndrome / Q000628:therapy; D003324:Coronary Artery Disease / Q000628:therapy*; D004359:Drug Therapy, Combination; D054855:Drug-Eluting Stents; D006083:Graft Occlusion, Vascular / Q000517:prevention & control; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D011475:Prosthesis Failure; D012307:Risk Factors; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D010975:Platelet Aggregation Inhibitors